Recombinant Bacillus subtilis Small, acid-soluble spore protein K (sspK)

Shipped with Ice Packs
In Stock

Description

Introduction

Bacillus subtilis is known for its ability to produce a wide range of bioactive compounds, making it adaptable to various environments . Recombinant Bacillus subtilis endospores have been employed in vaccines against tetanus and anthrax . Furthermore, they can be engineered to express proteins like the SARS-CoV-2 spike protein, potentially creating vaccine-like supplements against respiratory infections .

Small, Acid-Soluble Spore Proteins (SASPs)

Small, acid-soluble spore proteins (SASPs) are a family of proteins that play a crucial role in the resistance of bacterial spores to various environmental stresses . During sporulation, Bacillus subtilis produces SASPs that bind to DNA, protecting it from damage caused by UV radiation, heat, and desiccation .

Recombinant Bacillus subtilis Expressing sspK

Recombinant DNA technology allows scientists to modify Bacillus subtilis to express specific proteins, including Small, acid-soluble spore protein K (sspK) . This involves introducing a gene encoding sspK into the Bacillus subtilis genome, resulting in the bacterium producing the protein .

Applications of Recombinant Bacillus subtilis sspK

Recombinant Bacillus subtilis expressing sspK has several potential applications:

  • Vaccine Development Recombinant Bacillus subtilis spores expressing foreign antigens, when administered orally or nasally, can trigger mucosal and humoral immune responses, indicating their potential as vaccines .

  • Biocontrol Agent Bacillus subtilis produces antimicrobial and antifungal compounds, making it a potential biocontrol agent against fungal plant pathogens .

  • Probiotic Supplement Spore-based probiotics utilizing Bacillus subtilis are being explored for human applications .

  • Enzyme Production Recombinant strains of Bacillus subtilis are used for enzyme production in fermentation facilities .

  • Antimicrobial Production: B. subtilis produces antimicrobial compounds like bacillaene, difficidin, and macrolactin, which exhibit antibacterial activities .

Research Findings

StudyFindings
Creating a Vaccine-like Supplement against Respiratory Infection Using Recombinant Bacillus subtilis Spores Expressing SARS-CoV-2 Spike Protein with Natural Products Engineered B. subtilis spores expressing the SARS-CoV-2 spike protein could stimulate the production of proinflammatory cytokines . Oral vaccination with these spores showed adjuvant effects, enhancing the immune response to the CoronaVac vaccine .
Recombinant Bacillus subtilis Expressing the Clostridium perfringens Alpha-Toxin Carboxy-Terminal Domain Elicits Protective Immunity in Mice Mice immunized with recombinant spores expressing a fragment of the Clostridium perfringens alpha-toxin showed significant immune responses, including neutralizing antibodies and protection against toxin challenge .
Evaluation of the Immunity Responses in Mice to Recombinant Bacillus subtilis Expressing VP28 Protein of White Spot Syndrome Virus Recombinant B. subtilis expressing the VP28 protein of white spot syndrome virus elicited robust mucosal and humoral immune responses in mice, suggesting its potential as a feed additive to enhance immunity in animals .
Proteomic Response of Bacillus subtilis Spores under High Pressure Combined with Moderate Temperature and Random Peptide Mixture LK Treatment High pressure combined with moderate temperature and antimicrobial peptides caused cortex hydrolysis and inner membrane damage in B. subtilis spores . Proteomic analysis revealed significant changes in protein abundance related to genetic information processing, metabolism, and cellular processes .
Bacterial Competition Reveals Differential Regulation of the pks Genes by Bacillus subtilis The expression of pks genes, which encode enzymes for synthesizing the antibiotic bacillaene, is regulated by the master regulator of development, Spo0A, through its repression of AbrB and the stationary-phase regulator, CodY . Deletions of degU, comA, and scoC disrupt the timing and level of pks gene expression .
Overview of the Antimicrobial Compounds Produced by Members of the Bacillus subtilis Group B. subtilis produces antimicrobial compounds like bacillaene, difficidin, and macrolactin, which exhibit antibacterial activities .
FINAL RISK ASSESSMENT OF BACILLUS SUBTILIS There were no unreasonable risks associated with the use of recombinant strains of Bacillus subtilis for enzyme production in fermentation facilities .
Spore-Based Probiotic Bacillus subtilis: Current Applications in Humans and Future Perspectives Spore-based probiotics utilizing Bacillus subtilis are being explored for human applications .

Product Specs

Form
Lyophilized powder

Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.

Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.

Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.

Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to ensure contents settle. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms maintain stability for 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.

The tag type is determined during production. Please specify your desired tag type for preferential development.

Synonyms
sspK; BSU08550; Small; acid-soluble spore protein K; SASP K
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
2-50
Protein Length
Full Length of Mature Protein
Purity
>85% (SDS-PAGE)
Species
Bacillus subtilis (strain 168)
Target Names
sspK
Target Protein Sequence
VRNKEKGFP YENENKFQGE PRAKDDYASK RADGSINQHP QERMRASGKR
Uniprot No.

Target Background

Database Links
Protein Families
SspK family
Subcellular Location
Spore core.

Q&A

What is sspK in Bacillus subtilis and how is it characterized?

SspK (encoded by the BSU08550 gene) is one of several minor small, acid-soluble proteins unique to spores of Bacillus subtilis . It belongs to the broader family of small, acid-soluble spore proteins (SASPs) that play crucial roles in spore resistance and dormancy.

Characterization methods:

  • Gene identification: PCR amplification using primers specific to the sspK gene sequence

  • Protein isolation: Acid extraction from purified spores followed by SDS-PAGE analysis

  • Localization: Immunofluorescence microscopy using anti-sspK antibodies

  • Expression pattern: qRT-PCR analysis during sporulation time course

SspK is expressed exclusively in the forespore compartment during sporulation, with transcription primarily regulated by the forespore-specific sigma factor σG .

What are the established protocols for recombinant expression of sspK?

Several expression systems can be used for recombinant production of sspK:

  • E. coli expression system:

    • Clone sspK gene into pET vectors with His-tag or GST-tag

    • Express in BL21(DE3) strain under IPTG induction

    • Purify using affinity chromatography

  • B. subtilis expression system:

    • Use promoters of varying strength from the B. subtilis genetic toolbox (e.g., P* promoter)

    • Optimize RBS sequences for translation efficiency

    • Incorporate strong transcription terminators

    • Example yields: 5-700 μM protein concentration depending on promoter-RBS combination

  • Spore surface display:

    • Fusion with spore coat proteins (CotB, CotC, or CotA) using -GGGEAAAKGGG- linker

    • Transformation into B. subtilis WB800N or similar strains

    • Spore purification by lysozyme treatment and PBS washing

    • Verification by Western blot and immunofluorescence microscopy

How do researchers isolate and purify native sspK from B. subtilis spores?

Extraction protocol:

  • Cultivate B. subtilis in sporulation medium (e.g., Difco's sporulation medium) for 48-72 hours

  • Harvest spores by centrifugation (4200×g, 10 min)

  • Treat with lysozyme (15 μg/mL) to remove vegetative cells

  • Wash spores 5 times with cold PBS

  • Extract SASPs with acid extraction buffer (0.25M HCl, pH 2.0) for 30 minutes at 4°C

  • Neutralize extract and precipitate proteins with TCA

  • Analyze by SDS-PAGE and identify sspK by Western blot or mass spectrometry

Purification yield: Typically 0.5-1.5 mg of total SASPs per gram of dry spores, with sspK representing approximately 3-5% of total SASPs .

What is the role of sspK in spore resistance compared to other SASPs?

SspK belongs to the minor SASPs in B. subtilis, distinct from the abundant α/β-type SASPs that bind DNA directly. Research has shown:

SASP TypeDNA BindingUV ProtectionHeat ResistanceChemical Resistance
α/β-type (sspA/B)Strong+++++++++
γ-typeWeak++++
Minor (incl. sspK)Variable+++

What are the methodological approaches for engineering recombinant B. subtilis strains with modified sspK variants?

For researchers creating sspK variants, the following approaches are recommended:

A. Site-directed mutagenesis:

  • Design primers containing desired mutations in the sspK coding sequence

  • Perform PCR using high-fidelity polymerase

  • Clone into modular Expression Operating Unit (EOU) vectors

  • Transform into competent B. subtilis using one-step transformation protocol

B. Domain swapping/protein fusion:

  • Identify functional domains through sequence alignment with other SASPs

  • Design chimeric proteins (e.g., sspK-sspE hybrids) to probe domain function

  • Create fusion proteins with fluorescent reporters or affinity tags

  • Express using optimized promoter-RBS combinations

C. Chromosomal integration strategies:

  • Use double-crossover recombination at the amyE locus using plasmids like pDG364

  • Alternatively, integrate at the native sspK locus through homologous recombination

  • Select transformants using appropriate antibiotic markers (e.g., chloramphenicol resistance)

  • Verify integration by PCR and sequencing

D. Inducible expression systems:

  • Place sspK variants under control of inducible promoters (IPTG, xylose)

  • Fine-tune expression using the tunable genetic parts library for B. subtilis

  • Monitor protein production throughout sporulation process

For optimal results, incorporation of genetic parts from the B. subtilis toolbox can provide precise control over expression levels spanning 5 orders of magnitude (0.05-700 μM) .

How can researchers analyze sspK's contribution to spore resistance against environmental stressors?

Experimental design for stress resistance assays:

  • UV radiation resistance:

    • Generate control and sspK-deficient spores

    • Expose spore suspensions to defined UV doses (0-1000 J/m²)

    • Enumerate survivors by plating on nutrient agar

    • Calculate survival rates relative to unexposed controls

    • Compare with other SASP mutants (e.g., sspA sspB)

  • Heat resistance:

    • Subject spores to heat treatment (80-100°C for 10-30 min)

    • Determine survival by colony counting

    • Analyze kinetics of spore killing at different temperatures

  • Chemical resistance:

    • Expose spores to hydrogen peroxide, formaldehyde, or acids

    • Quantify survival after various exposure times

    • Determine if sspK contributes to specific chemical resistance profiles

  • Desiccation resistance:

    • Air-dry spores on glass coverslips

    • Store under controlled relative humidity conditions (0-33% RH)

    • Recover at defined intervals and determine viability

    • Monitor loss of sspK protein during storage by Western blot

  • Simulated environmental stress:

    • Expose spores to simulated Mars surface conditions (as described in )

    • Monitor survival and mutation frequency

    • Assess specific contribution of sspK in this multi-stress environment

When conducting these experiments, it's important to include appropriate controls:

  • Wild-type spores

  • sspA sspB double mutants (lacking major α/β SASPs)

  • sspE mutants (lacking the most prominent SASP)

  • Multiple SASP mutants (e.g., sspA sspB sspK)

Research has shown that sspK's contribution may only become evident in multiple SASP-deficient backgrounds due to functional redundancy among SASPs .

What techniques are available for studying sspK interactions with DNA and other spore components?

To investigate sspK's molecular interactions, researchers can employ these methods:

A. DNA-binding characterization:

  • Electrophoretic Mobility Shift Assay (EMSA):

    • Incubate purified recombinant sspK with labeled DNA fragments

    • Analyze complex formation by native PAGE

    • Determine binding constants and sequence preferences

  • Atomic Force Microscopy (AFM):

    • Visualize sspK-DNA complexes at nanometer resolution

    • Track conformational changes in DNA upon sspK binding

    • Compare with known α/β-type SASP-DNA structures

  • DNase I footprinting:

    • Map specific sspK binding sites on DNA sequences

    • Identify protected regions indicating protein-DNA interactions

B. Spore component interactions:

  • Chemical cross-linking coupled with mass spectrometry:

    • Cross-link proteins in intact spores using formaldehyde

    • Extract and analyze by LC-MS/MS

    • Identify proteins that co-purify with sspK

  • Immunoprecipitation from spore extracts:

    • Use anti-sspK antibodies to pull down protein complexes

    • Identify interaction partners by Western blot or mass spectrometry

  • Bacterial two-hybrid analysis:

    • Screen for protein-protein interactions in vivo

    • Identify potential binding partners among spore proteins

  • Förster Resonance Energy Transfer (FRET):

    • Create fluorescent protein fusions with sspK and potential partners

    • Measure energy transfer indicating close molecular proximity

    • Monitor interactions during spore formation and germination

These techniques can reveal how sspK contributes to the complex protein network that maintains spore dormancy and resistance properties.

What regulatory mechanisms control sspK expression during sporulation?

SspK expression is tightly regulated during sporulation through several mechanisms:

  • Sigma factor dependence:

    • Expression is primarily controlled by the forespore-specific sigma factor σG

    • The promoter contains consensus sequences centered 10 and 35 nucleotides upstream of the transcription start site that are recognized by σG

  • Promoter analysis techniques:

    • Create promoter-reporter fusions using fluorescent proteins

    • Introduce mutations in putative regulatory elements

    • Monitor activity throughout sporulation process

    • Analyze by flow cytometry or microscopy to quantify expression levels

  • Chromatin immunoprecipitation (ChIP):

    • Use antibodies against RNA polymerase or sigma factors

    • Identify direct binding to the sspK promoter region

    • Map temporal binding patterns during sporulation stages

  • Transcriptional start site mapping:

    • Use 5' RACE or RNA-seq to identify precise transcription initiation points

    • Analyze differences between wild-type and regulatory mutants

  • Small RNA regulation:

    • Screen for sRNAs that affect sspK expression

    • Use methods like PARE-seq or CLASH to identify RNA-RNA interactions

Understanding the precise regulatory mechanisms controlling sspK expression can provide insights into sporulation gene hierarchies and potential applications for controlled heterologous protein expression.

How can sspK be utilized in biotechnological applications such as surface display on B. subtilis spores?

SspK can be leveraged for various biotechnological applications:

A. Spore surface display system development:

  • Create fusion constructs between sspK and proteins of interest

  • Design optimal linker sequences (e.g., GGGEAAAKGGG) to maintain function of both partners

  • Express in sporulation-competent B. subtilis strains

  • Verify display using immunofluorescence and flow cytometry

  • Quantify display efficiency by Western blot analysis

B. Applications in vaccine development:

  • Create sspK fusions with antigenic epitopes or proteins

  • Express on spore surface during sporulation

  • Test stability under simulated gastrointestinal conditions (SGF/SIF)

  • Evaluate immune responses in animal models

  • Assess neutralizing antibody production

C. Enzyme immobilization platform:

  • Generate sspK-enzyme fusion proteins

  • Display on spore surface

  • Test enzymatic activity and stability

  • Develop reusable biocatalyst systems

D. Biosensor development:

  • Create sspK fusions with reporter proteins or binding domains

  • Engineer spores for environmental monitoring applications

  • Develop detection systems for specific molecules

When designing fusion proteins, researchers should consider:

  • Optimal fusion orientation (N- or C-terminal)

  • Linker composition and length for proper folding

  • Potential interference with spore formation

  • Effect on spore resistance properties

  • Stability and activity of the displayed heterologous protein

Research has demonstrated that B. subtilis spores expressing fusion proteins can maintain viability under harsh conditions and elicit immune responses when administered orally , making this an attractive platform for multiple biotechnological applications.

What are the experimental considerations when studying the role of sspK in maintaining spore dormancy?

Investigating sspK's role in dormancy maintenance requires specialized approaches:

A. Germination rate analysis:

  • Generate wild-type, sspK knockout, and complemented strains

  • Induce germination with various germinants:

    • L-alanine (1-10 mM)

    • AGFK mixture (asparagine, glucose, fructose, K+)

    • Dodecylamine (non-physiological germinant)

  • Monitor germination kinetics by:

    • OD600 decrease (indicating cortex hydrolysis)

    • Phase-contrast microscopy (loss of refractility)

    • DPA release (fluorescence with terbium)

  • Calculate germination rates and efficiency

B. Dormancy stability assessment:

  • Store spores at various temperatures (4°C, 25°C, 37°C)

  • Monitor spontaneous germination over time

  • Assess viability at regular intervals (weeks/months)

  • Compare with other SASP mutants

C. Molecular changes during dormancy:

  • Analyze sspK-DNA interactions in dormant vs. germinating spores

  • Monitor protein modifications:

    • Phosphorylation status

    • Degradation patterns during germination

  • Track changes in spore core hydration using:

    • FTIR spectroscopy

    • NMR analysis

    • Cryo-electron microscopy

D. Metabolic activity detection:

  • Use metabolomics approaches to identify dormancy-specific molecules

  • Measure ATP levels in dormant spores

  • Detect RNA synthesis using radioactive precursors

  • Analyze protein synthesis using fluorescent amino acid analogs

When designing these experiments, it's important to consider:

  • The potential redundancy among SASPs, requiring analysis of multiple mutants

  • The heterogeneity in spore populations, necessitating single-spore analysis

  • The technical challenges in working with dormant spores due to their resistance properties

  • The need for appropriate controls to distinguish sspK-specific effects from general SASP functions

Understanding sspK's role in dormancy may reveal new insights into the fundamental biology of bacterial persistence and have applications in controlling spore germination in various contexts.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.